Zindel will stand for election at Fresenius’ Annual General Meeting on May 13.
A member of Siemens Healthineer’s managing board, Zindel’s responsibilities at the German medtech giant include imaging, advanced therapies, technology excellence, quality and regulatory, the Healthineers Performance System, and sustainability.
Zindel will replace Klaus-Peter Müller, 77, who has been on the Supervisory Board and its Audit Committee since 2008.
Medtronic (NYSE:MDT) is making leadership changes in its diabetes, surgical robotics and cardiac rhythm management operating units.
Que Dallara joins the medtech giant as EVP and president of the diabetes business, Mike Marinaro is now the president of surgical robotics and Dr. Kweli Thompson has been appointed as president of cardiac rhythm management at Medtronic.
Get the full story at our sister site, MassDevice.
Medtronic (NYSE:MDT) today confirmed leadership transitions for its diabetes, surgical robotics and cardiac rhythm management operating units.
Que Dallara joins the medtech giant as EVP and president of the diabetes business, Mike Marinaro is now the president of surgical robotics and Dr. Kweli Thompson has been appointed as president of cardiac rhythm management at Medtronic.
“The future of medical technology requires strong leadership in data science, artificial intelligence, and robotics, all of which make these three Operating Unit President roles some of the most important and dynamic leadership opportunities in our industry,” Medtronic Chairman and CEO Geoff Martha said in a news release. “These appointments not only strengthen our businesses and build our technology expertise; they also further establish Medtronic as a destination for world-class talent.”
Dallara will join Medtronic’s executive committee on May 2, …
BioSig Technologies (NSDQ:BSGM) today announced that it has appointed John Sieckhaus as chief operating officer.
Sieckhaus joins the company with 30 years of experience in the healthcare industry. He has served in numerous leadership roles at St. Jude Medical and Abbott Labs, including senior VP and general manager. Most recently, Sieckhaus was VP of field clinical affairs for Abbott where he created a field clinical and monitoring team to support clinical trials across multiple business units in Abbott’s Cardiovascular portfolio.
“I am very excited to join this team and look forward to building upon the foundation of the Pure EP system and its capabilities. Focusing in the area of electrophysiology by providing better solutions in identifying and treating complex arrhythmias for our clinical customers and patients will be extremely rewarding,” Sieckhaus said in a news release.
“We are pleased to welcome John to the team as we bui…
Mario Chaves Jr., engineering manager at Okay Industries [Image courtesy of Okay Industries]
Okay Industries (New Britain, Conn.) announced today that it has promoted Mario Chaves Jr. to an engineering manager role overseeing its engineering team in Alajuela, Costa Rica.Chaves joined Okay as a machinist about 10 years ago. Over the years, he worked in production control, purchasing, facilities, IT and other areas, becoming an essential member of the strategic management team.
In his new role, he’ll oversee the Alajuela engineering team’s growth and development, and manage its strategy ad budget.
“During the last decade, Mario has been a model for finding new ways to improve our processes and adding new technologies that have allowed us to become more competitive,” said Sean Stowik, Okay’s director of sales and marketing. “He has also created a strong engineering team that has el…
Conformis (NSDQ:CFMS) this week announced that Denise Pedulla was appointed chief legal officer and corporate secretary.
Prior to joining the Billerica, Massachusetts-based company, Pedulla served as the general counsel and corporate secretary for NeoGenomics. She has also held numerous leadership roles at Berkeley Research Group, Orthofix and Fresenius Medical Care.
“We are pleased to announce the addition of Denise Pedulla as chief legal officer and corporate secretary. Her strong public company experience and leadership capabilities will help support our growth strategy and further strengthen our executive team,” president and CEO Mark Augusti said in a news release. “I look forward to the contributions she will make as a member of the Conformis team.”
Augmedics announced today that it appointed a new independent director to its board and a new chief marketing officer.
Chicago-based Augmedics confirmed that Nadav Tomer will join as an independent director, while Reed Krider will be chief marketing officer (CMO).
Tomer joins with 23 years of global experience, having retired from Johnson & Johnson in January after most recently serving as the global president of spine for J&J’s DePuy Synthes Companies.
Augmedics’ addition of Tomer to its board of directors follows the January appointment of former Bardy Diagnostics CEO Kevin Hykes as president and CEO.
“Nadav’s experience at the helm of one of the most comprehensive spine portfolios in the world is an invaluable addition to our board,” Hykes said in a news release. “We are excited to leverage his expertise to continue to build on our position as the market-leading AR surgical guidance system for spinal procedures. I am thrille…
Illumina (Nasdaq:ILMN) announced today that it appointed Carissa Rollins as its new chief information officer.
A 30-year veteran of business technology transformation and digital and consumerization strategy, Rollins joins San Diego-based Illumina having most recently served as chief information officer (CIO) at UnitedHealthcare. Her appointment was made effective today.
Rollins’ responsibilities at UnitedHealthcare included strategy and technology investments supporting commercial, Medicare and retirement and government programs technology business portfolios. Prior to UnitedHealthcare, Rollins held leadership positions at Gander Mountain, Kohl’s, Manpower Global and Miller-Coors.
“I look forward to joining the Illumina team and building upon the high-performance teams, ensuring that key stakeholders have a continuously improved experience with IT services and support,” Rollins said in a news release. “For me, by focusing o…
King joined San Francisco-based iRhythm’s board in July 2012 and served as the company’s president and CEO from then until January 2021.
“On behalf of the entire iRhythm team, I would like to thank Kevin for his contributions over the last several years,” iRhythm President and CEO Quentin Blackford said in a news release. “iRhythm would not be the company that it is today without Kevin’s leadership and we thank him for the many achievements during his tenure. I am personally grateful to Kevin for him welcoming me into the company and ensuring a smooth transition.”
King led the company, which develops the Zio XT ambulatory cardiac monitor, a wearable ECG device meant to be smaller and more comfortable than a traditional Holter monitor while still offering acc…
“Big Sky Biomedical was founded to enhance early-stage innovation and development in some of the fastest-growing segments of healthcare, including neurovascular, structural heart, and regenerative medicine,” Egeland in a news release out today.
“I’m extremely excited to apply my scientific, medical, and commercial experience to our portfolio companies in a much broader and deeper capacity,” Egeland said. “Alongside our exceptional teams of engineers, scientists, operators, and physician partners, I look forward to addressing significant underserved patient populations and large unmet clinical needs through compelling and differentiated technologies.”
Founded by a group of medical device serial entrepreneurs in the cardiovascu…
Minnetronix Medical (St. Paul, Minnesota) announced today that it has hired Travis Hintz as its VP of operations.
Hintz was previously the global supply chain director for the personal safety division at 3M. He has also been VP of North America supply chain planning for Ecolab and operations manager at Delphi Automotive Systems.
In his new role, Hintz will work to scale manufacturing and supply chain operations to support Minnetronix’s growing number of customers. Minnetronis presently supports more than 100 medical device companies within its four key technology segments: optical systems, RF energy, stimulation and active wearables, and fluid and gas management devices.
“Travis’ breadth of experience working with global companies across the spectrum of supply chain, procurement, production, and planning will be invaluable to support our growth,” said Minnetronix Medical CEO Jeremy Maniak. He added that Hintz’s experience integrating acquisitions, levera…
Cardiovascular Systems (NSDQ:CSII) announced today that it appointed Dr. Jeffery W. Chambers as its chief medical officer.
St. Paul, Minnesota-based Cardiovascular Systems said in a news release that Chambers served as the primary investigator for the Orbit II study — the pivotal trial supporting premarket approval for the use of orbital atherectomy in coronary arteries. He has also served as a consultant in connection with Cardiovascular Systems’ product development, quality assurance, medical affairs and clinical research.
“I am excited to join CSI and I look forward to working with the team to bring innovative and important technologies to underserved patient populations,” Chambers said in the release. “In doing so, together, we will improve the health of people with coronary and peripheral artery disease and fulfill our mission.”
Chambers has been employed at the Metropolitan Heart and Vascular Institute since 1995 and, as an entrep…